Astellas Pharma still looks to grow in cancer with a pipeline that includes internally developed programs that could stand out in oncology. But the drugmaker sees additional growth opportunities in ophthalmology and neuromuscular disorders, Chief Medical Officer Tadaaki Taniguci said.
Be part of INVEST 2025, happening May 20-21 in Chicago! Join investors and healthcare's brightest entrepreneurs as they connect, collaborate, and spark innovation. This premier event is your opportunity to engage in dynamic discussions and forge meaningful connections that drive transformative change in healthcare.
Recognizing its vulnerability to cybercrime, the healthcare industry continues to prioritize cybersecurity. Here are some areas where organizations should be focusing their efforts.
Understanding how site augmentation services could be leveraged to overcome challenges is not the responsibility of one entity. The most creative and effective solutions arise from collaboration among all stakeholders — sponsors, CROs, service providers, and research sites.
No comments